Sodium-Glucose Cotransporter-2 Inhibitors and the Risk of Abnormal Serum Potassium Level.
Y Joseph HwangBeini LyuAlexander R ChangLesley A InkerMorgan E GramsJung-Im ShinPublished in: Clinical journal of the American Society of Nephrology : CJASN (2021)
Keyphrases